This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v4.0.0-ballot: STU4 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 3.0.0. For a full list of available versions, see the Directory of published versions

Value Sets

Value Sets Defined by mCODE

The following value sets are defined in this implementation guide:

• BenignUncertainNeoplasmBrainCNSDisorderVS
• BinetStageValueVS
• BodyLocationAndLateralityQualifierVS
• BodyLocationQualifierVS
• BrachytherapyPermanentSeedsTechniqueVS
• BrachytherapyLowDoseRateTemporaryTechniqueVS
• BrachytherapyPulsedDoseRateTechniqueVS
• BrachytherapyRadiopharmaceuticalTechniqueVS
• BrachytherapyHighDoseRateElectronicTechniqueVS
• BrachytherapyHighDoseRateTechniqueVS
• BrachytherapyModalityVS
• BrachytherapyTechniqueVS
• BreslowDepthStageValueVS
• CancerBodyLocationVS
• CancerDiseaseStatusEvidenceTypeVS
• CancerDisorderVS
• CancerRelatedSurgicalProcedureVS
• CancerStageValueVS
• CancerStagingMethodVS
• CancerStageTypeVS
• CarcinomaInSituDisorderVS
• ClarkLevelValueVS
• ClinOrPathModifierVS
• ConditionStatusTrendVS
• CytologicEvidenceOfMalignancyVS
• FIGOStagingMethodVS
• FIGOStageValueVS
• GleasonGradeGroupValueVS
• HistologyMorphologyBehaviorVS
• HistoryOfMetastaticMalignantNeoplasmVS
• HumanSpecimenTypeVS
• HypereosinophilicSyndromeDisorderVS
• LateralityQualifierVS
• LymphomaStagingMethodVS
• LymphomaStageValueVS
• LymphomaStageValueModifierVS
• MelanomaInSituDisorderVS
• PrimaryCancerDisorderVS
• PrimaryMalignantNeoplasmDisorderVS
• ProcedureIntentVS
• RadiotherapyModalityVS
• RadiotherapyTechniqueVS
• RadiotherapyTreatmentLocationQualifierVS
• RadiotherapyTreatmentLocationVS
• RadiotherapyVolumeTypeVS
• RaiStagingMethodVS
• RaiStageValueVS
• SecondaryCancerDisorderVS
• TeleradiotherapyCarbonIonBeamTechniqueVS
• TeleradiotherapyElectronBeamTechniqueVS
• TeleradiotherapyModalityVS
• TeleradiotherapyNeutronTechniqueVS
• TeleradiotherapyPhotonBeamTechniqueVS
• TeleradiotherapyProtonBeamTechniqueVS
• TeleradiotherapyTechniqueVS
• TNMDistantMetastasesCategoryVS
• TNMDistantMetastasesCategoryMaxVS
• TNMDistantMetastasesStagingTypeVS
• TNMDistantMetastasesStagingTypeMaxVS
• TNMPrimaryTumorCategoryVS
• TNMPrimaryTumorCategoryMaxVS
• TNMPrimaryTumorStagingTypeVS
• TNMPrimaryTumorStagingTypeMaxVS
• TNMRegionalNodesCategoryVS
• TNMRegionalNodesCategoryMaxVS
• TNMRegionalNodesStagingTypeVS
• TNMRegionalNodesStagingTypeMaxVS
• TNMStageGroupVS
• TNMStageGroupMaxVS
• TNMStageGroupStagingTypeVS
• TNMStageGroupStagingTypeMaxVS
• TNMStagingMethodVS
• TreatmentTerminationReasonVS
• TumorMarkerTestVS
• TumorSizeMethodVS
• TumorSizeUnitsVS

The following draft (maturity level 0) value sets are defined in this implementation guide:

• ALLRiskAssessmentVS
• CancerRiskAssessmentTypeVS
• DeauvilleScaleVS
• HistologicBehaviorAndTypeVS
• HistologicGradeVS
• HistologicGradingSystemVS
• LanskyPlayPerformanceStatusVS
• LymphomaStageBulkyModifierVS
• NeuroblastomaINSSValueVS
• NeuroblastomaINRGSSValueVS
• NormalizationBasisVS
• RhabdomyosarcomaClinicalGroupValueVS
• RhabdomyosarcomaAssessmentValueVS
• RiskAssessmentValueVS
• WilmsTumorBodySiteVS
• WilmsTumorStageValueVS

External Value Sets Used in mCODE

• [ECOG performance status]
• [Karnofsky performance status]
• [Medication Clinical Drug (RxNorm)]